← Back to Search

Plant-based Protein Blend

Plant-Based Protein for Healthy Nutrition (PBP Trial)

N/A
Waitlist Available
Led By Stuart Phillips, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female, between the ages of 18 - 30 years (inclusive)
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before, and 30, 60, 120, 180 and 300 minutes after test drinks are consumed.
Awards & highlights

PBP Trial Summary

This trial will compare the effects of a plant-based protein to whey protein on muscle building.

Who is the study for?
This trial is for healthy non-smokers aged 18-30 with a BMI of 18-30 kg/m2. Participants must have regular menstrual cycles without hormonal contraceptives if female, and be in good health as confirmed by a questionnaire. Those using steroids, analgesics, anti-inflammatories or corticosteroids, or with chronic illness or muscle diseases cannot join.Check my eligibility
What is being tested?
The study is testing how well a new plant-based protein blend helps build muscle compared to whey protein isolate. It's designed to see if the plant protein can match the muscle-building response that whey protein typically produces.See study design
What are the potential side effects?
Since this trial involves dietary proteins, side effects might include digestive discomfort such as bloating or gas. However, serious side effects are unlikely given the nature of the intervention.

PBP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 30 years old.

PBP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after test drink are consumed.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after test drink are consumed. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Muscle protein synthesis
Secondary outcome measures
Aminoacidemia
Appetite and desire for specific food types in response to test drinks types H
Palatability of test drinks
+2 more

PBP Trial Design

3Treatment groups
Experimental Treatment
Group I: Whey protein isolateExperimental Treatment1 Intervention
Whey protein isolate is the 'gold standard' of protein supplements due to being rich in essential amino acids and leucine. Leucine is a key amino acid the is required to stimulate muscle protein synthesis. Muscle protein synthesis is the major mechanism the underpins muscle growth. The whey protein would ostensibly serve as a positive control.
Group II: Plant based protein isolate + leucineExperimental Treatment1 Intervention
Enriching plant-based protein with leucine will increase the 'quality' of said protein source and theoretically should have similar muscle protein synthetic responses to whey protein.
Group III: Plant based protein isolateExperimental Treatment1 Intervention
Current plant-based protein isolates available contain insufficient amounts of leucine, and are less digestible, resulting in a reduced muscle protein synthesis responses. The plant based protein would ostensibly serve as a negative control.

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,597,820 Total Patients Enrolled
1 Trials studying Healthy Nutrition
24 Patients Enrolled for Healthy Nutrition
Stuart Phillips, PhDPrincipal InvestigatorMcMaster University
8 Previous Clinical Trials
169 Total Patients Enrolled

Media Library

Protein Quality (Plant-based Protein Blend) Clinical Trial Eligibility Overview. Trial Name: NCT05139160 — N/A
Healthy Nutrition Research Study Groups: Whey protein isolate, Plant based protein isolate, Plant based protein isolate + leucine
Healthy Nutrition Clinical Trial 2023: Protein Quality Highlights & Side Effects. Trial Name: NCT05139160 — N/A
Protein Quality (Plant-based Protein Blend) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05139160 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for participants in this scientific trial?

"Affirmative. According to clinicaltrials.gov, this research trial is currently enrolling participants which was initially announced on August 15th 2022 and recently revised on the 22nd of that very same month. Just 8 patients need to be recruited from 2 separate sites."

Answered by AI

Is my demographic profile suitable to participate in this research endeavor?

"This experiment is looking for 8 participants that are physically healthy, aged between 18 and 30 years old. Prospective candidates should be male or female, have a BMI within the range of 18-30 kg·m2, not smoke tobacco products, demonstrate regular menstruation without any hormonal contraception usage; as well as pass an overall health assessment questionnaire."

Answered by AI

How many participants are being accepted into this clinical research endeavor?

"Affirmative. According to clinicaltrials.gov, this clinical trial is currently recruiting patients and has been since August 15th 2022. The most recent update was on the 22nd of that same month. As part of their search for research participants, they are seeking 8 individuals at two different sites."

Answered by AI

Does the current research protocol extend to include geriatric participants?

"For this trial, the age requirement is between 18 to 30. For those below 18 and above 65 years old, there are 4 studies and 10 studies respectively offered for them."

Answered by AI

Who else is applying?

What state do they live in?
Ontario
How old are they?
18 - 65
What site did they apply to?
Changhyun Lim
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Aminoacidemia and Protein Kinetics in Response to the Ingestion of Plant-based Protein Blends
Stuart Phillips 2022. "Aminoacidemia and Protein Kinetics in Response to the Ingestion of Plant-based Protein Blends". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05139160.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top